Consultancy Services

India’s pharmaceutical industry is currently valued at approximately USD 50 billion in FY 2023–24, comprising around USD 23.5 billion in domestic sales and USD 26.5 billion in exports. The sector has established itself as a

The Indian clinical trials market is rapidly expanding, making it an attractive destination for global pharmaceutical companies. With a market size of over $1.5 billion and an annual growth rate exceeding 12%, India stands out

India has emerged as a preferred destination for clinical trials, driven by its robust regulatory framework, cost advantages, and high-quality research infrastructure. With a market size exceeding $1.5 billion and over 2,500 clinical trials conducted